Home Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
 

Keywords :   


Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases

2014-01-13 12:01:01| Biotech - Topix.net

Genzyme, a Sanofi company , and Alnylam Pharmaceuticals, Inc. announced today that they have significantly expanded their strategic agreement to develop and commercialize treatments for rare genetic diseases.

Tags: expand rare collaboration diseases

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11Costume
24.11BB S604ULS
24.1133
24.11 ElectronicAudioExperimentsDude Incedible
24.11 TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »